Imperial College London Centenary
About Imperial
About ImperialContacts/getting hereAlumniResearchCoursesAbout this site
Select your text size  for this site here: Small Text Normal Text Large Text Extra Large Text

Note: Some of the graphical elements of this site are only visible to browsers that support accepted web standards. The content of this site is, however, accessible to any browser or Internet device.


Imperial scientist named in top 100 young innovators list

See also...
-Materials web site
External Sites:
-Technology Review web site
-TR100 website
(Imperial College is not responsible for the content of these external internet sites)

For immediate release
20 September 2004

Materials research that has the potential to transform the way patients with chronic illnesses are treated is recognised today by Technology Review. Dr Molly Stevens of Imperial College London is named in the magazine's 2004 list of the world's 100 Top Young Innovators (TR100), published annually to showcase the work of international researchers under the age of 35.

Dr Stevens, 30, lecturer in nanotechnology and tissue engineering in the Department of Materials, is recognised for her work in developing intelligent drug delivery systems that can monitor the body and respond directly, and also in pioneering nanotechnology approaches towards the regeneration of tissues. She explains:

"By taking inspiration from the complex self-assembly processes that occur in nature we have been able to develop self-assembled materials that can be dynamically controlled under physiological conditions. Since the new materials can respond to subtle changes in the body they could have tremendous potential in future nanodevices, biosensors and advanced drug delivery systems.

"It's very exciting and an honour for me to have the research recognised by the TR100."

Professor John Kilner, Head of the Department of Materials, adds: "The whole department is thrilled that Molly has been included in the 2004 TR100 list, and we all offer her our warmest congratulations. We see this award as a recognition of Molly's pioneering work at the interface between materials science and bio-nanotechnology. The opportunities for innovation in this field are enormous and we anticipate that some important new technological developments in the field of tissue engineering and regenerative medicine will result from her work."

Technology Review is a monthly magazine focusing on innovation and emerging technologies that have the potential to change the way we live. Executive Editor David Rotman says:

"In the five years since we began naming our annual selection of the world's top innovators under age 35, inclusion among the TR100 has become one of the most prestigious awards for young innovators around the world. This year's winners are all pioneering fascinating innovations in the fields of biomedicine, computing and nanotechnology, and were chosen after a rigorous selection and judging process. The result is an elite group whose visions and inventions will shape the future of technology."

The TR100 researchers will be honoured at Technology Review's Emerging Technologies Conference at MIT on 29-30 September. Their work will be featured in the magazine's October 2004 edition.

For further information contact:

For Imperial College London and Molly Stevens:
Abigail Smith
Imperial College London Press Office
Tel: 020 7594 6701
Mobile: 07803 886248

For TR100 and Technology Review:
Kristen Collins
KMC Partners
Tel: 00 1 617 833 5574

Notes to editors

About Technology Review, Inc

Technology Review, Inc., an MIT Enterprise, delivers essential information about emerging technologies and their impact on business leaders. Since 1998, paid circulation for the company's magazine, Technology Review, has more than tripled, climbing from 92,000 to 315,000. Combined with its signature events, newsletters, and online businesses, Technology Review reaches over two million business leaders throughout the world each month.

About TR100

TR100 is Technology Review's list of 100 young people whose contributions to emerging technologies are poised to profoundly influence our world. The 2004 TR100's panel of judges includes senior executives from organisations including Boston University, Caltech, Cambridge University, CombinatoRx, Concept2Company, Cornell University, General Electric, Geekcorps, Georgia Tech, Harvard Medical School, Hewlett-Packard, IBM, Intellectual Ventures, Microsoft, MIT, Northwestern University, PureTech Ventures, Singapore Institute of Bioengineering and Nanotechnology, TIAX, Wharton, Xerox, and YankeeTek Ventures.

About Molly Stevens

Molly Stevens is currently Lecturer in Nanotechnology and Tissue Engineering. She joined Imperial in 2004 after spending several years as a Postdoctoral Associate working with Professor Robert Langer in the Chemical Engineering Department at the Massachusetts Institute of Technology (MIT). She graduated from Bath University with a first class honours degree in Pharmaceutical Sciences. She was then awarded a PhD in biophysical investigations of specific biomolecular interactions and single biomolecule mechanics from the University of Nottingham (2000). These studies were also awarded the Ronald Belcher Memorial Lecture Award from the Royal Society of Chemistry (2000). She has also previously been awarded both the Janssen Prize and the UpJohn Prize for academic excellence and research. Her pioneering work on tissue regeneration at MIT, has led to the setting up of a human clinical trial for bone regeneration. Her current research in regenerative medicine includes the directed differentiation of stem cells, the design of novel bioactive scaffolds and new approaches towards tissue regeneration. In the field of nanotechnology she has current research efforts in exploiting specific biomolecular recognition and self-assembly mechanisms to create new dynamic nano-materials, biosensors and drug delivery systems.

About Imperial College London

Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (11,000) and staff (6,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture.